China Go-to-Market Strategy for a Multinational Pharmaceutical Firm
The Challenge
A multinational pharmaceutical manufacturer was planning to launch one of its leading products in China. They wanted a better understanding of their product’s market in China so that they could refine their go-to-market strategy.
Our Solution
SmithStreet conducted research into treatment options in China, competitors and relevant government regulations in order to provide the client with the industry landscape for their product in China. By analyzing the opportunities and challenges faced in the market, we recommended that our client aggressively promote its product launch. Based on our recommendation, the client decided to focus heavily on entering the China market.
Phase I: Global Treatment Options
- Using desk research, we compiled epidemiological data on the product’s targeted diseases
- We outlined global treatment options, including Western and traditional Chinese medicine
Phase II: China Treatment Options
- Using qualitative data, we analyzed past, current, and anticipated trends for disease treatment
- We outlined the competitive landscape and conducted research into competing products
- We identified and summarized relevant government rules and regulations
Phase III: Analysis and Recommendations
- We conducted a SWOT analysis for the product market in China
- Based on our analysis, we provide the client with a go-to-market strategy for China